Roche has appointed Daniel O'Day, current COO of Roche Diagnostics, to be COO of Roche Pharma. O'Day replaces Pascal Soriot, who has left Roche to become CEO of AstraZeneca. Roland Diggelmann will succeed O'Day as COO of Roche Diagnostics, the company said.
Diggelmann, who currently is head of the Asia-Pacific region within Roche Diagnostics, also has been appointed to be a new member of the executive committee by the board of directors. Diggelmann joined Roche in 2008, and he formerly worked in sales and marketing in Europe and the Asia-Pacific region with Sulzer Medica/Centerpulse and Zimmer.
O'Day has held various positions at Roche since he started with Roche Pharmaceuticals in 1987, including serving as head of molecular diagnostics.